SCHEMBL1472555

SCHEMBL1472555

COC(=O)CCCCCNc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.66
HDAC1 Q13547 4/20 0.54
HDAC3 O15379 2/20 0.54
HDAC2 Q92769 2/20 0.54
NCOR2 Q9Y618 1/20 0.54
ALDH1A1 P00352 4/20 0.52
MAPT P10636 2/20 0.52
KDM4E B2RXH2 1/20 0.50
GAA P10253 1/20 0.50
HSD17B10 Q99714 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
PTPRC P08575 2/20 0.46
PTPN13 Q12923 1/20 0.46
TSHR P16473 2/20 0.45
LTB4R Q15722 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC10 Q969S8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9756822 0.93 LMNA (0.60) LMNAHDAC1HDAC3HDAC2NCOR2
SCHEMBL8979411 0.88 HDAC1 (0.55) LMNAHDAC1HDAC3HDAC2NCOR2
SCHEMBL505867 0.86 LMNA (0.55) LMNAALDH1A1MAPTKDM4EHSD17B10
SCHEMBL8705157 0.86 ALDH1A1 (0.68) LMNAHDAC1HDAC3HDAC2NCOR2
SCHEMBL11404787 0.86 ALDH1A1 (0.68) LMNAHDAC1HDAC3HDAC2NCOR2
SCHEMBL11402051 0.86 KDM4E (0.53) LMNAALDH1A1MAPTKDM4EGAA
SCHEMBL11398508 0.84 KDM4E (0.52) LMNAALDH1A1MAPTKDM4EGAA
SCHEMBL11409170 0.84 KDM4E (0.52) LMNAALDH1A1MAPTKDM4EGAA
SCHEMBL11119111 0.84 GAA (0.58) LMNAHDAC1HDAC3HDAC2ALDH1A1
SCHEMBL10108013 0.84 ALDH1A1 (0.70) LMNAHDAC1HDAC3HDAC2NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915428-B2 Photorefractive dendron compound, photorefractive dendrimer compound, method of preparing the same, photorefractive device using the same, and method of manufacturing the device SAMSUNG ELECTRONICS CO., LTD. (KR) 2011-03-29 US disclosed
US-20090223627-A1 PHOTOREFRACTIVE DENDRON COMPOUND, PHOTOREFRACTIVE DENDRIMER COMPOUND, METHOD OF PREREPARING THE SAME, PHOTOREFRACTIVE DEVICE USING THE SAME, AND METHOD OF MANUFACTURING THE DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2009-09-10 US disclosed
EP-0080154-B1 N-SUBSTITUTED 2-PYRIDYL INDOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR THERAPEUTICAL USE CIBA-GEIGY AG (CH) 1985-08-28 EP disclosed
US-4478842-A THROMBOXANE SYNTHETASE INHIBITORS CIBA-GEIGY CORPORATION (US) 1984-10-23 US disclosed
EP-0080154-A2 N-substituted 2-pyridyl indoles, process for their preparation, pharmaceutical compositions containing them, and their therapeutical use CIBA-GEIGY AG (CH) 1983-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090223627-A1 PHOTOREFRACTIVE DENDRON COMPOUND, PHOTOREFRACTIVE DENDRIMER COMPOUND, METHOD OF PREREPARING THE SAME, PHOTOREFRACTIVE DEVICE USING THE SAME, AND METHOD OF MANUFACTURING THE DEVICE KISS1R, CROCC, DBN1 LMNA 526/4885HDAC1 3362/4885HDAC3 1342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.